Inland Imaging kicks off new liver cancer study

Treatment tailors doses to patient, tumor size

By Natasha Nellis at the Spokane Journal of Business

Inland Imaging LLC has enrolled the first patient in a new liver cancer treatment trial.

Using what’s known as Y-90 radiation therapy, the treatment uses microscopic beads filled with yttrium-90 isotope “designed to be delivered directly into tumors through the arteries that feed the tumors,” says Dr. Douglas Murrey, an interventional radiologist at Inland Imaging. Once in place, the radioactive isotope destroys the surrounding tissue from within the tumor.

Read the rest of the article at the Spokane Journal of Business.